Munich - Delayed Quote EUR

Numinus Wellness Inc. (LR23.MU)

0.0268

0.0000

(0.00%)

At close: January 20 at 8:04:03 AM GMT+1

Numinus Provides Bi-Weekly Update on Annual Filings

Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a leader in mental health care specializing in innovative and evidence-based treatments, today provided an update with respect to its previously announced management cease trade order ("MCTO") in connection with the Company's filing of its audited annual financial statements (the "Audited Financial Statements"), management discussion and analysis (the "MD&A"), and annual information form (the "AIF") for the financial

CNW Group 7 days ago

NUMIF
When Can We Expect A Profit From Numinus Wellness Inc. (TSE:NUMI)?

With the business potentially at an important milestone, we thought we'd take a closer look at Numinus Wellness Inc.'s...

Simply Wall St. last month

NUMIF
Numinus Wellness Closes Sale of Clinics and Launches Initiative to Increase Access to Mental Health Care

Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, announces the closing of the previously announced definitive agreement with Stella, an interventional psychiatry practice focused on treating PTSD, anxiety and depression with biological modalities, of the sale of the Company's five Wellness Clinics in

CNW Group last month

NUMIF
Numinus Applies for Management Cease Trade Order

Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a leader in mental health care specializing in innovative and evidence-based treatments, announces that it has requested a temporary Management Cease Trade Order ("MCTO") from the British Columbia Securities Commission ("BCSC") in connection with the Company's filing of its audited annual financial statements (the "Audited Financial Statements") and MD&A for the financial year ended August 31, 2024.

CNW Group 2 months ago

NUMIF
Numinus Wellness Announces Sale of Clinics and Unique Data Partnership to Increase Access to Mental Health Care

Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, announces that it has executed a definitive agreement with Stella, an interventional psychiatry practice focused on treating PTSD, anxiety and depression with biological modalities, for the sale of the Company's five Wellness Clinics in Utah (the "Agre

PR Newswire 2 months ago

NUMIF
Numinus Wellness Comments on FDA Decision on New Drug Application for MDMA-Assisted Therapy for PTSD

Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a leader in mental health care specializing in innovative and evidence-based treatments, comments on the U.S. Food and Drug Administration's ("FDA") decision to not approve Lykos Therapeutics' new drug application for MDMA (midomafetamine capsules) used in combination with psychological intervention for individuals with post-traumatic stress disorder ("PTSD"). According to a news release issued by Lykos Therapeutics,

CNW Group 5 months ago

NUMIF
Numinus Wellness Third Quarter 2024 Earnings: Misses Expectations

Numinus Wellness ( TSE:NUMI ) Third Quarter 2024 Results Key Financial Results Revenue: CA$4.35m (down 28% from 3Q...

Simply Wall St. 6 months ago

NUMIF
When Will Numinus Wellness Inc. (TSE:NUMI) Turn A Profit?

Numinus Wellness Inc. ( TSE:NUMI ) is possibly approaching a major achievement in its business, so we would like to...

Simply Wall St. 6 months ago

NUMIF
Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results

Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, today announced its financial results for the three months ended May 31, 2024 ("Q3 2024").

PR Newswire 6 months ago

NUMIF
Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024

Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioural health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, will release its financial results for the quarter ended May 31, 2024, after market close on Thursday, July 11, 2024.

CNW Group 6 months ago

NUMIF
Numinus Wellness Announces Resignation of Director

Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, announces the resignation of Donna Wong as a director of the Company effective Monday, June 24, 2024.

PR Newswire 6 months ago

NUMIF
Numinus Wellness Announces Strategic Acquisition of MedBright AI

Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, announces execution of a letter of intent (the "LOI") to acquire MedBright AI Investments Inc. ("MedBright AI") (CSE: MBAI) by way of a statutory plan of arrangement (the "Proposed Transaction").

CNW Group 6 months ago

NUMIF

MBAIF
MedBright AI Announces Strategic Acquisition by Numinus Wellness

Plans name change to “Numinus Intelligence” leveraging its current revenue generating operations to AI-enable mental health clinics across the US The strategic combination merges MedBright’s AI-enabled clinical solution capabilities with Numinus’ deep data and vast experience with drug-assisted mental health treatment to improve clinical operations and capitalize on reimbursable offeringsLeaders from MedBright AI team with extensive experience in US healthcare clinic operations and ownership pla

GlobeNewswire 6 months ago

NUMIF

MBAIF
Numinus Clarifies Disclosures

Vancouver, British Columbia--(Newsfile Corp. - June 7, 2024) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company advancing traditional and innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, wishes to clarify two news releases disseminated on May 30, 2024, titled "Numinus and Cybin Embark on a Groundbreaking Journey: Pioneering Phase 3 Trials for Major Depressive Disorder" ("Release

Newsfile 7 months ago

NUMIF
Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD

Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a leader in mental health care specializing in innovative and evidence-based treatments, comments on the results of June 4, 2024 meeting of the U.S. Food and Drug Administration's ("FDA") Psychopharmacologic Drugs Advisory Committee ("PDAC"). The independent committee reviewed Lykos Therapeutics' new drug application for MDMA (midomafetamine capsules) used in combination with psychological intervention for individuals

CNW Group 7 months ago

NUMIF
Numinus Wellness Announces Voting Results From its Annual General Meeting of Shareholders

Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is pleased to announce the voting results from its annual general meeting of shareholders (the "Meeting"), held earlier today. A total of 50,266,506 common shares representing 15.68% of the 320,551,600 issued and outstanding common shares of the Company as

CNW Group 7 months ago

NUMIF
Numinus Wellness Charts Path To Profitability While Strengthening Community Ties

Vancouver, British Columbia--(Newsfile Corp. - May 30, 2024) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus'' or the "Company"), a leader in mental health care and in advancing evidence-based psychedelic-assisted therapies, announces a strategic blueprint aimed at fortifying its footprint across the United States.Through a comprehensive cost optimization initiative, Numinus is poised to strengthen its already established network of U.S. wellness clinics and cutting-edge clinical re

Newsfile 7 months ago

NUMIF
Numinus and Cybin Embark on a Groundbreaking Journey: Pioneering Phase 3 Trials for Major Depressive Disorder

Vancouver, British Columbia--(Newsfile Corp. - May 30, 2024) - In a significant stride towards transforming mental health care, Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23) has proudly announced that its research site, Cedar Clinical Research (CCR), has been selected for Cybin's Phase 3 pivotal multinational clinical trial of CYB003. Aimed at revolutionizing the treatment of Major Depressive Disorder (MDD), this collaboration marks a pivotal moment in the journey toward understan

Newsfile 7 months ago

NUMIF
Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted Therapy

Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, announces that Health Canada has approved the Company's Clinical Trial Application to examine the feasibility of a group model in MDMA-assisted psychotherapy enrolling trainee practitioners as participants.

PR Newswire 7 months ago

NUMIF
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support

Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a leader in mental health care specializing in innovative and evidence-based treatments, announces a strategic plan designed to streamline expenses and sharpen the company's focus on its higher-growth U.S. operations. This initiative is designed to enhance its U.S. wellness clinics and clinical research facilities and expand visibility and enrollment in its practitioner training program. Additionally, the plan support

PR Newswire 8 months ago

NUMIF

Performance Overview

Return	LR23.MU	S&P/TSX Composite index
YTD	0.00%	+2.24%
1-Year	-74.43%	+20.40%
3-Year	-94.46%	+18.70%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Numinus Wellness Inc. (LR23.MU)

Numinus Provides Bi-Weekly Update on Annual Filings

When Can We Expect A Profit From Numinus Wellness Inc. (TSE:NUMI)?

Numinus Wellness Closes Sale of Clinics and Launches Initiative to Increase Access to Mental Health Care

Numinus Applies for Management Cease Trade Order

Numinus Wellness Announces Sale of Clinics and Unique Data Partnership to Increase Access to Mental Health Care

Numinus Wellness Comments on FDA Decision on New Drug Application for MDMA-Assisted Therapy for PTSD

Numinus Wellness Third Quarter 2024 Earnings: Misses Expectations

When Will Numinus Wellness Inc. (TSE:NUMI) Turn A Profit?

Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results

Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024

Numinus Wellness Announces Resignation of Director

Numinus Wellness Announces Strategic Acquisition of MedBright AI

MedBright AI Announces Strategic Acquisition by Numinus Wellness

Numinus Clarifies Disclosures

Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD

Numinus Wellness Announces Voting Results From its Annual General Meeting of Shareholders

Numinus Wellness Charts Path To Profitability While Strengthening Community Ties

Numinus and Cybin Embark on a Groundbreaking Journey: Pioneering Phase 3 Trials for Major Depressive Disorder

Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted Therapy

Numinus Wellness Focused on Boosting Profitability and Expanding Community Support

Performance Overview